City

Bethesda (1)

Columbus (1)

Madison (1)

New York (1)

Pittsburgh (1)

Sacramento (1)

Shanghai (1)

Overall Status

Recruiting (2)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

Dragonboat Biopharmaceutical Company Limited (1)

National Cancer Institute (NCI) (1)

Collaborator

Fudan University (1)

Intervention

cisplatin (1)

elimusertib (1)

gemcitabine hydrochloride (1)

human anti-pd-l1 monoclonal antibody injection (ldp) (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (1)

NIH (1)

Study Type

Interventional (2)

advanced penile carcinoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Advanced Bile Duct Carcinoma, Advanced Breast Carcinoma, Advanced Cervical Carcinoma Trial in United States (Cisplatin,

Recruiting

Advanced Bile Duct Carcinoma
+33 more

Cisplatin
+2 more

Sacramento, California
+6 more

Aug 11, 2022

Bladder Cancer, Renal Carcinoma, Advanced Penile Carcinoma Trial in Shanghai (Human Anti-PD-L1 Monoclonal Antibody Injection

Recruiting

Bladder Cancer
+2 more

Human Anti-PD-L1 Monoclonal Antibody Injection (LDP)

Shanghai, Shanghai, China

Dragonboat Biopharmaceutical,Co.,Ltd

Jan 17, 2021